Study Design. A cross-sectional study of 1804 consecutive patients.
L ower back pain (LBP) is a worldwide issue with prevalence averaging 30% in the US 1 ; onset most often occurs between the ages of 30 and 50 years. LBP is also associated with extensive medical expenses and work-related disability, and it should thus be effectively and rapidly treated. Clinical spinal pathologies including LBP involve several kinds of pain. Neuropathic pain (NeP) is pathological pain derived from neural damage or from physiological nociceptive pain (NocP), and it has been reported in However, these data do not include details regarding the location of the pain such as the lower back, buttock, or legs. Although such location-related information is not typically taken into account in current treatment design and clinical decision-making for LBP, we believe that understanding the characteristic details of the pain such as the association between the particular pain symptoms and their locations will enable clinicians to suggest more efficient treatment strategies. Furthermore, these analyses can provide additional information for resolving the pathologies of nonspecific LBP, that is, LBP without an exact pathoanatomical diagnosis, which accounts for as much as 85% of LBP patients. 4 In particular, pain location has not been well addressed in previous studies, which has resulted in a rather obscure understanding of pain characterizing, that is, that radiating leg pain can be NeP.
The current study aimed to reanalyze the data provided by the JSSR to determine the prevalence of NeP prevalence in lumbar spinal disorders, with a specific focus on characterizing the pain according to its location.
MATERIALS AND METHODS

Subjects
The current study analyzed the data from an existing crosssectional study that was conducted on 2025 outpatients recruited from 137 Japanese medical institutions, including orthopedic hospitals with at least 20 beds, general hospitals, and university hospitals. The participating institutions were selected from regions throughout Japan, that is, from eight major districts listed here from north to south: Ten institutions from Hokkaido, 9 from Tohoku, 45 from Kanto, 11 from Tokai, 7 from Hokuriku, 24 from Kansai, 13 from Chugoku-Shikoku, and 18 from Kyushu. 3 The institutional ethics committee of each participating institution approved the study protocol.
The subjects were LBP patients with/without leg pain who visited the outpatient clinics mentioned above, and were diagnosed with spinal disease associated with LBP (described later in the Results section) by officially certified Japanese spine surgeons in the participating medical institutions between March and November 2010. The participating surgeons were officially certified by the JSSR as having sufficient experience with diagnosing and operating on spinal disorder patients; each surgeon had experienced at least 200 operative cases. The included patients met all of the following inclusion criteria. Each patient signed an informed consent form, and then filled out questionnaires regarding their pain and health status on site. 3 Patient data included the NeP screening questionnaire score (described below) and the location of the pain (lower back, buttock, or legs). -like pain  1  1  1  1  0  Q2  Electric shock-like pain  0  0  0  0  1  Q3  Tingling burning pain  0  1  1  1  1  Q4  Pain with strong numbness  0  1  1  1  1  Q5  Only a light touch with clothing or cold  wind causes a pain   0  1  3  3  3 
Inclusion Criteria
Q6
Site of pain has decreased or increased sensation
Q7
Site of pain shows skin swelling and/or discoloration to red or purple
The Japanese NeP screening questionnaire 5 is a selfadministered questionnaire based on a previous study that characterized NeP. 6 The patients' answers to the sevenquestion domains were weighted and scored (Table 1) . Patients also drew their pain location directly into the manikin printed along with the questionnaire. The drawing was directly and faithfully traced to the digital database by independent third-party observers, as is shown in Figure 2 .
The likelihood of NeP was determined on the basis of the total score, as follows: !5, highly likely to be experiencing NeP (2þ); 4, likely to be experiencing NeP (þ); 3, possible NeP (AE); 2, unlikely to be experiencing NeP (-). This screening tool has been validated in the Japanese population and reported to have 87.7% sensitivity and 71.7% specificity for detection of NeP, when a score of !4 is regarded as presence of NeP. 5 Therefore, in the current study, patients with a score !4 were characterized as experiencing NeP, whereas patients with a score <4 were characterized as experiencing NocP.
Each certified spine surgeon distributed the questionnaires, and the primary researcher-in-charge for the study collected the data; the data collection was performed fairly and objectively. The data were transferred correctly and electrically by an independent organization using FileMaker Pro 10 software (FileMaker, Santa Clara, CA). The pain locations were classified into four main areas: lower back, buttock, upper thigh, and lower thigh (Figure 1 ). These basic areas and various combinations comprised a total of 15 areas (Figure 1) . Figure 2A illustrates all 15 combinations. Figure 2B and C shows actual examples.
The demographic data were analyzed by unpaired t test, and the pain distribution was statistically assessed by using the Chi-square test followed by Fisher test to determine the existence of significant differences in pain location. All statistical analyses were performed using PASW statistics ver. 18 
RESULTS
This study was conducted in a cohort of 1804 patients aged 20 to 79 years with chronic LBP (Figure 3) . Patients who did not meet the inclusion criteria were excluded at the first visit. In total, 221 patients were excluded on the basis of the inclusion/exclusion criteria or because their data were incomplete (197 patients with pain in nonlumbar regions and 24 patients with inadequate data). The included patients were categorized into NeP (n ¼ 737) and NocP (n ¼ 1067) groups. Figure 1 . Pain location scheme. 1: lower back, the area between the waist and the greater trochanter level. 2: buttock, the area between the greater trochanter and the gluteal sulcus, 3: upper thigh, 4: lower thigh. The other 11 areas (5-15) were determined by combining these four basic locations. Table 3 summarizes the diagnosis and pain demographic data. Degenerative disorders were present in the majority (1760, 97.6%) of the subjects, among which the most common diagnosis was lumbar spinal stenosis (938 patients), followed by lumbar disc herniation or disease (380 patients), and spondylolisthesis (367 patients). Table 4 summarizes the distribution of the pain. Pain located at the lower back and buttocks accounted for approximately 30% of the cases, followed by leg pain, including pain of the upper and lower thighs. Figure 4 illustrates the distribution by arranging the data according to whether or not the patient had leg pain, that is, the subgroups were divided into two categories, leg pain and no leg pain (blue tag: leg pain -, red: leg pain þ). Patients with leg pain accounted for more than half of the cases. NocP patients without leg pain were more prevalent than NeP patients.
Pain Distribution
Pain Distribution Analysis
On the basis of the representative data provided in Figure 4 , we characterized the pain location.
Initially, we evaluated how the existence of LBP (area 1) and buttock pain (area 2) were associated with the type of pain pathology. The prevalence of NeP was significantly decreased when LBP was present (P < 0.01, Figure 5A ). The existence of buttock pain was significantly and positively associated with the prevalence of NeP regardless of whether the subjects were experiencing leg pain ( Figure 5B, C) .
We then evaluated the presence and distribution of leg pain in patients without LBP. Buttock pain was also significantly and positively associated with the prevalence of NeP in no-LBP patients with leg pain (P < 0.01, Figure 6A ). Furthermore, to investigate how the location of leg pain is associated with the type of pain pathology, we evaluated upper thigh ( Figure 6B ) and lower thigh pain ( Figure 6C ). Lower thigh pain was significantly and positively associated with NeP prevalence, which thus suggests that the leg pain is more neuropathic when lower thigh pain is present.
The prevalence of NeP was 31.9% in the LBP subjects in the current cross-sectional study, which has been already reported in the previous study. 3 In LBP-only cases, the pain distribution [NocP(%)/ NeP(%)] was 44/22, whereas in LBP with leg pain, it was 56/78. Buttock pain overlapped with LBP and leg pain with regard to the induction of NeP.
DISCUSSION
The current cross-sectional study revealed an NeP prevalence of 31.9% in LBP subjects, and the pain distribution [NocP(%)/NeP(%)] was 44/22 and 56/78 in LBP-only and These results are important in a point that pain location can indicate its pathology because the location of the pain has not typically been indicated the type of pain pathology without specific NeP screening tool. The results of the present study can help the primary care physician to estimate what type of pain the patient is experiencing (especially NeP vs. NocP) and then to design the treatment strategy accordingly.
A previous survey revealed that 15 .4% of Japanese adults have chronic musculoskeletal pain. The lumbar region is the most affected (65%), followed by the neck and shoulder regions, indicating a high incidence of chronic pain related to spinal disorders. Regarding LBP, the current study found that the pain is more nociceptive if LBP is dominant, whereas NeP is more dominant if the patient has buttock and/or leg pain with lumbar disorders. The reason why axial LBP is more nociceptive is unclear because its pathology is still undetermined. It is known that inflammatory mediators such as tumor necrosis factor (TNF)-a, nerve growth factor (NGF), and interleukin (IL)-6 are produced in components of the lumbar spine including the intervertebral discs, dorsal root ganglion, and spinal nerves. Several trials have been conducted to suppress these mediators by administering inhibitors such as etanercept (anti-TNFa-inhibitor) and tocilizumab (anti-IL6-receptor antibody) to the lumbar spinal region, and these inhibitors were shown to have analgesic effects. [7] [8] [9] The presence of inflammatory mediators in the painful lumbar components and the analgesic effect of their inhibition support the present hypothesis that LBP is associated with nociceptive pain rather than NeP.
Buttock pain can be considered a part of sciatica, 10 and the results of the current study support this concept. Such pain should be treated as NeP. Buttock pain results from several pathologies such as piriformis syndrome; however, the certified spinal surgeons whom we worked with largely excluded these pathologies. For greater accuracy, the hip joint should be assessed for pain and decreased range of motion, which can cause buttock or groin symptoms.
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Pain that radiates to the lower extremities is clinically divided into two types: radicular pain radiating below the knee and psuedoradicular pain, which does not cross the knee. 12 Upper thigh pain can be associated with pain in other regions such as the hip joint, whereas lower thigh pain is associated with radicular pain derived from lumbar disease such as lumbar disc herniation. This association with nerve damage or injury is why the NeP prevalence was higher in patients with lower thigh pain. The current study underlines the importance of treating buttock pain as an independent factor to detect NeP in LBP patients because pains originating in these regions can be associated with different pathologies. Currently, the diagnosis of neuropathic components in LBP is difficult because a gold standard examination is lacking, as the diagnostic value of anamnesis and physical examination has not been well documented. This has halted progress in LBP diagnosis, which is still based on history taking and clinical judgment. A recent review defined the LBP area as ''the area bounded by the lowest palpable ribs superiorly and the gluteal folds inferiorly,'' 13 but this is not a universal criterion. The perceived location of LBP depends on the physician's background, which can lead to regional differences in diagnosis. 14 One of the major current findings, that buttock pain is a source of NeP, should also be used to define the area of the ''lower back'': The criterion that buttock pain should include an NeP component in certain conditions is clinically significant, as many LBP patients have an unrecognized NeP component that may result in suboptimal treatment because NeP requires a different therapeutic approach. 12 The findings in the current study may thus indicate a new pharmacological strategy for LBP patients.
In addition, the current study suggests strategies for NeP treatment. Thus far, there have been several reports of treatment of NeP related to some certain diseases, but not all of the treatments were clinically effective. For example, patients with chronic regional pain syndrome (CRPS) are considered to be experiencing NeP, but adequate therapies have not yet been established. 15 Patients with sickle cell disease have an NeP prevalence of 37%, but only 5% of them take an NeP drug. 16 The current study indicates that LBP-dominant cases can be treated with anti-inflammatory or anti-nociceptive drugs such as NSAIDs, whereas cases with buttock pain and/or leg pain can be treated with NeP drugs such as pregabalin 17 or gabapentin. Correct understanding of the nature of the pain and appropriate prescription will lead to more appropriate, patient-oriented pain control and also help to reduce treatment costs, because treatment for neuropathic LBP is more costly than treatment for nociceptive LBP. 18 In dealing with NeP, we should keep in mind that the diagnosis of NeP can be vague because it relies on the evaluation of information provided by the patient and physical findings obtained by the clinician; these indicia are sometimes not sufficiently objective. 19 Considering that musculoskeletal NeP can be still underdiagnosed compared with other types of NeP such as CRPS when using the NeP screening tool, 20 it is important to be particularly aware of the possible NeP in patients with the lumbar spine disorders as indicated in the current study.
It should also be noted that the current study mainly included LBP patients with a specific diagnosis. These patients diagnosed with LBP patients can include patients who were ever previously diagnosed with nonspecific LBP; such patients are reported to comprise approximately 85% of all LBP cases. 4 Considering that nonspecific LBP can involve psychosocial environmental factors in addition to organic alterations 21 that can affect the properties of the pain, appropriate specific diagnosis by certified spine surgeons is important to support and clarify the results of the current study by excluding psychosocial aspects. In addition, considering that LBP of at least moderate intensity and duration has an annual incidence in the adult population of 10% to 15%, 1 it is important to investigate the properties of the LBP in detail in the context of other musculoskeletal disorders.
In conducting a large-scale population study such as the current study, it is necessary to consider possible biases. The current study involved more than 200 certified spine surgeons participating from 137 Japanese medical institutions, and these surgeons were involved from the primary diagnosis to surgery with a specific standard. The qualified nature of the evaluations obtained from the 137 institutions can thus be considered an advantage in diminishing possible bias. In addition, the lowest required sample size (n) was calculated as 384 using a standard power analysis formula:
, with response rate ( p): 0.5, sampling error (d): 5%, confidence level: 95%, and l: 1.96. On the basis of this analysis, our sample size of over 1800 is considered to be adequate for the current study.
The current study has some limitations. First, it was a large cross-sectional study, and it was difficult to collect detailed data such as the level of the spinal pathology in addition to the detailed physiological and radiological findings including disc bulging and herniation. In addition, the cross-sectional data collection did not include socio-demographic characteristics such as work status, compensation, and education. These points may have affected data accuracy. A categorized evaluation based on demographical data such as age, sex, and disease duration should be considered in the future because these factors can work as both potential confounders and effect modifiers in observational study designs. Furthermore, the study design may have been associated with some inherent bias, as it mainly included subjects with a specific diagnosis even though there is a large population with nonspecific LBP. It should also be noted that the pathological state was not constant among the subjects. Furthermore, slight LBP patients do not require clinic visit, which can lead to obscure external validity. We have to keep in mind that the current study does not provide the whole picture of those with LBP. Lumbar spinal stenosis can develop as the result of several pathologies such as compression of spinal nerves or the cauda equine-either intracanal or intra/extraforamen. The ensuing effects can overlap with those of other degenerative pathologies, resulting in complicated symptoms that can be a major obstacle in large-scale prospective studies.
The current findings may also be insufficient because of inadequacy of the screening tool itself, which can fail to identify approximately 10% to 20% of patients with clinician-diagnosed NeP. 12 Other screening tools can identify potential patients with NeP, which may offer guidance for further diagnostic evaluation and pain management. The PainDETECT questionnaire is one such NeP screening tool that has recently gained popularity, and its validity and reliability for NeP has already been confirmed. [22] [23] [24] [25] [26] [27] Use of such a questionnaire may have revealed clearer findings in our cohort, but was not available in Japan when the current study was being conducted. In addition, possible transcription errors may have occurred when tracing and digitizing the pain location, although the impact of such errors should have been minimized given the large number of subjects.
In conclusion, the LBP subjects included in the current cross-sectional study had an NeP prevalence of 31.9%. The NeP distribution was 22% of LBP-only cases and 78% of in LBP with leg pain cases. It is thus important to note that LBP alone appears to be associated with NocP rather than NeP, whereas buttock pain is significantly associated with NeP prevalence regardless of whether or not leg pain exists. Leg pain can include NeP, especially when it contains a peripheral element.
Key Points
Pathological pain prevalence and its distributional features were investigated in low back pain (LBP) patients with chronic lumbar spinal disorders. LBP subjects showed 31.9% of NeP prevalence, and the pain distribution showed [NocP(%)/ NeP(%)], low back pain only cases: 44/22, while low back pain with leg pain cases showed a prevalence of 56/78. LBP without buttock pain induces nociceptive pain rather than neuropathic pain (NeP). Buttock pain is significantly associated with NeP prevalence whether or not leg pain exists. Leg pain can include NeP prevalence, especially when it contains a peripheral element.
